Cross Country Healthcare (NASDAQ:CCRN) PT Lowered to $15.00

Cross Country Healthcare (NASDAQ:CCRN) had its price objective lowered by equities researchers at Truist Financial from $17.00 to $15.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has a “hold” rating on the business services provider’s stock. Truist Financial’s price target would suggest a potential upside of 25.00% from the company’s current price.

Separately, Barrington Research dropped their price target on shares of Cross Country Healthcare from $21.00 to $19.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $19.20.

Cross Country Healthcare Trading Down 0.2 %

CCRN stock opened at $12.00 on Monday. The business’s fifty day moving average price is $13.72 and its 200 day moving average price is $14.84. Cross Country Healthcare has a 12-month low of $11.64 and a 12-month high of $23.64. The company has a market capitalization of $417.29 million, a PE ratio of 9.23, a P/E/G ratio of 2.37 and a beta of 0.63.

Cross Country Healthcare (NASDAQ:CCRN) last issued its quarterly earnings results on Wednesday, July 31st. The business services provider reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.04). The business had revenue of $339.77 million for the quarter, compared to analysts’ expectations of $334.75 million. Cross Country Healthcare had a return on equity of 7.29% and a net margin of 0.54%. The firm’s revenue for the quarter was down 37.2% on a year-over-year basis. During the same quarter last year, the company earned $0.69 earnings per share. Research analysts predict that Cross Country Healthcare will post 0.52 EPS for the current fiscal year.

Insider Buying and Selling

In other Cross Country Healthcare news, insider Karen Mote sold 13,829 shares of the firm’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $17.08, for a total value of $236,199.32. Following the sale, the insider now directly owns 24,696 shares in the company, valued at $421,807.68. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, insider Karen Mote sold 13,829 shares of the stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $17.08, for a total value of $236,199.32. Following the transaction, the insider now owns 24,696 shares in the company, valued at approximately $421,807.68. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Cynthia Ann Grieco sold 1,945 shares of the company’s stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $17.21, for a total value of $33,473.45. Following the completion of the transaction, the vice president now directly owns 7,605 shares of the company’s stock, valued at $130,882.05. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.90% of the stock is owned by insiders.

Institutional Investors Weigh In On Cross Country Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. nVerses Capital LLC purchased a new position in shares of Cross Country Healthcare during the second quarter worth about $50,000. GAMMA Investing LLC lifted its stake in Cross Country Healthcare by 622.4% in the second quarter. GAMMA Investing LLC now owns 5,678 shares of the business services provider’s stock valued at $79,000 after buying an additional 4,892 shares during the last quarter. Denali Advisors LLC boosted its holdings in shares of Cross Country Healthcare by 3,885.5% in the first quarter. Denali Advisors LLC now owns 5,500 shares of the business services provider’s stock valued at $103,000 after acquiring an additional 5,362 shares during the period. SG Americas Securities LLC purchased a new position in shares of Cross Country Healthcare during the third quarter worth approximately $135,000. Finally, EMC Capital Management acquired a new position in shares of Cross Country Healthcare in the 1st quarter valued at $155,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.